Publication | Closed Access

KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program

HepatologyMedicinePathologyCancer BiologySorafenib ToleranceLiver CancerOncologyCell BiologyHepatocellular CarcinomaTumor BiologyCancer Growth